ADMA
ADMA BIOLOGICS, INC.
Latest close $9.26 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 9 parsed filing(s) · 6 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Invesco CIK0000914208 | Dec 31, 2025 observed Feb 12, 2026 filed · 43d Schedule 13G amendment | Reported reduction | 11.8M -1.1M | 12.00% 0.00 pts | $18.24 | $15.59 | $9.26 |
| State Street CIK0000093751 | Jun 30, 2025 observed Aug 11, 2025 filed · 42d Initial Schedule 13G | Initial Schedule 13G | 12.1M +637.7K | 12.00% 0.00 pts | $18.21 | $16.38 | $9.26 |
| State Street CIK0000093751 | Mar 31, 2025 observed May 13, 2025 filed · 43d Initial Schedule 13G | Initial Schedule 13G | 11.4M | 12.00% | $19.84 | $19.88 | $9.26 |